Mallinckrodt
News/ News/ Sales and Marketing
Mallinckrodt pays $260m to settle kickback, rebate fraud charges
Phil Taylor
liability, litigation, Mallinckrodt, US
0 Comment
FDA knocks back Mallinckrodt’s kidney drug terlipressin
Phil Taylor
kidney disease, liver disease, Mallinckrodt, regulatory, terlipressin
0 Comment
News/ News/ Sales and Marketing
Mallinckrodt moves closer to resolving its opioid liability hangover
Phil Taylor
bankruptcy, litigation, Mallinckrodt, opioid crisis
0 Comment
AI device cleared by FDA to spot lesions during colonoscopy
Phil Taylor
artificial intelligence, colorectal cancer, Cosmo Pharma, digital, digital health, Mallinckrodt, screening
0 Comment
Mallinckrodt’s liver disease drug terlipressin edges FDA advisory panel
Phil Taylor
fda, kidney disease, liver disease, Mallinckrodt, rare disease, terlipressin
0 Comment
Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial
Phil Taylor
coronavirus, infectious disease, Mallinckrodt, Novoteris
0 Comment
News/ News/ News/ Patients/ Sales and Marketing
Mallinckrodt proposes $1.6bn deal to settle opioid litigation
Phil Taylor
litigation, Mallinckrodt, opioid crisis
0 Comment
Purdue preps bankruptcy as opioid settlement bid stumbles; report
Phil Taylor
litigation, Mallinckrodt, opioid crisis, Purdue Pharma
0 Comment